This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation Protein Therapeutics Summit

$700 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
September 28-30, 2022
Boston Convention and Exhibition Center

Haruki Hasegawa, PhD
Principal Scientist at Amgen Inc.


Haruki is a molecular cell biologist who investigates the processes of in vivo protein folding and intracellular trafficking of therapeutically important proteins. His main interests are: (1) elucidating cargo-specific biosynthetic mechanisms for broad classes of proteins; (2) determining the fate of proteins in intracellular and extracellular space after the synthesis; and (3) translating the findings into effective protein expression strategies, assay designs, and mechanistic understanding of disease biology. After receiving a Ph.D. in Molecular Cell Biology from the University of Michigan, Haruki undertook a postdoctoral training at the National Institutes of Health. In Amgen, Haruki works closely with disease area specialists, geneticists, and assay technology experts to advance early exploratory projects from target validation and proof-of-concept studies to lead selection and optimization. He also collaborates with scientists in process development and formulation groups to characterize antibody therapeutics and the mAb-producing recombinant CHO cell lines.

Speakers at this event